Main
>
ONCOLOGY (**)
>
Kidney Cancer>RCC>MET ***
>
Treatment
>
USA. M. PembrolizuMAb+Axitinib
>
(*) USA Approval Date: 2019. 04.22
(*) USA Approval Date: 2019. 04.22's products
This section has no products